More NewsRead More
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Revance Therapeutics, Inc. - RVNC
June 11, 2015
from PR Newswire
RVNC INVESTOR ALERT: Investigation of Revance Therapeutics, Inc. Announced by Glancy Prongay & Murray LLP
June 16, 2015
Revance Therapeutics to Initiate Two Key Trials for RT001, Its Topical Botulinum Toxin Type A Investigational Drug Product Candidate
June 03, 2015
EQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Revance Therapeutics, Inc.
June 10, 2015
Revance Therapeutics to Release First Quarter 2015 Financial Results Wednesday, May 13, 2015
April 29, 2015
Revance Therapeutics Releases Fourth Quarter and Full Year 2014 Financial Results and Reiterates 2015 Outlook
March 02, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here